OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Clinical Pharmacology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
	273
Triple antithrombotic therapy and dual therapy – What is the evidence base?	96
Acalabrutinib CYP3A‐mediated drug–drug interactions: Clinical evaluations and physiologically based pharmacokinetic modelling to inform dose adjustment strategy	67
Issue Information	64
Postoperative ileus after digestive surgery: Network meta‐analysis of pharmacological intervention	58
Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects	55
Serum uric acid lowering mediated by glucagon‐like peptide‐1 receptor agonists: Emerging considerations	54
Older adults' adherence to medications and willingness to deprescribe: A substudy of a randomized clinical trial	53
Antidepressants are not safe during pregnancy and in women of child‐bearing age	53
Sensitivity of estimated tacrolimus population pharmacokinetic profile to assumed dose timing and absorption in real‐world data and simulated data	51
Issue Highlights	50
Effects of intraoperative low‐dose esketamine on postoperative pain after vestibular schwannoma resection: A prospective randomized, double‐blind, placebo‐controlled study	48
Intranasal vitamin B₁₂ administration in elderly patients: A randomized controlled comparison of two dosage regimens	48
Regulatory authority and clinical acceptability: Physicians' responses to regulatory drug safety warnings	47
Analysis of factors influencing the relationship between voriconazole plasma concentrations and adverse effects in a paediatric population	46
Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing	45
Incidence, clinical classification and risk factors of cyclosporin A‐induced liver injury in allogeneic haematopoietic stem cell transplant recipients	45
Design of a pharmacokinetic/pharmacodynamic model for administration of low dose peripheral norepinephrine during general anaesthesia	45
Epidural methadone and morphine pharmacokinetics and clinical effects in healthy volunteers: A randomized, crossover‐design trial	41
Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin	39
Modelling the progression of illicit substance use patterns from real‐world evidence	39
Comparison of a polypharmacy‐based scale with Charlson comorbidity index to predict 6‐month mortality in chronic complex patients after an ED visit	39
Does coprescribing nonsteroidal anti‐inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?	38
Health technology assessment of paediatric medicines: European landscape, challenges and opportunities inside the conect4children project	36
Opioid‐related deaths and their counterpart by occurrence era, age group and coimplicated drugs: Scotland vs. England and Wales	35

Pharmacokinetics, safety and efficacy study in pregnancy and existing cumulative data/evidence to support clinical use and labelling of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in pre	35
Selected Abstracts from Pharmacology 2024	35
Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID‐19 Requiring invasive ventilation Meta‐Trial (CHARTER‐MT): Protocol and statistical analysis plan for an investigat	34
Impact of codeine rescheduling on prescribing of codeine and other opioids: Interrupted time series analyses using Australian general practice data	34
Lemborexant levels in breast milk after single doses in healthy, lactating women	33
Chemometrics as a valuable tool for evaluating interactions between antiretroviral drugs and food	33
A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID‐19 mRNA vaccination	33
A first‐in‐human study of the anti‐inflammatory profibrinolytic TMS‐007, an SMTP family triprenyl phenol	33